CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Open-market sale Director sold 1,038,284 shares at an average $6.11 ($6,339,418)
- 144 Insider Sale of Securities
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes EVP, CFO gave up 33,642 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 83,766 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes President and CEO gave up 9,588 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO gave up 4,935 shares (to pay taxes)
- 4 Grant or award Director acquired 24,040 shares (grant or award)
- 4 Grant or award President and CEO acquired 557,728 shares (grant or award)
- 4 Grant or award Director acquired 24,040 shares (grant or award)
- 4 Grant or award Director acquired 24,040 shares (grant or award)
- 4 Grant or award Director acquired 24,040 shares (grant or award)
- 4 Grant or award Director acquired 24,040 shares (grant or award)
- 4 Grant or award Director acquired 24,040 shares (grant or award)
- 10-K Report Annual Report
- 8-K Event Executive or director change · Other events
Page 10 of 50 · 1,000 filings